Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Honvo, G, Bannuru, RR, Bruyère, O et al. (9 more authors) (2019) Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Drugs and Aging, 36 (Suppl 1). pp. 145-159. ISSN 1170-229X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2019, The Author(s). This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Dates:
  • Accepted: 28 February 2019
  • Published (online): 9 May 2019
  • Published: April 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 May 2019 11:11
Last Modified: 24 May 2019 11:14
Status: Published
Publisher: Springer (Adis)
Identification Number: https://doi.org/10.1007/s40266-019-00667-8

Share / Export

Statistics